TOL.ST
Price:
$0.477
Market Cap:
$129.25M
Toleranzia AB, a biotechnology company, develops and commercializes drugs for the treatment of autoimmune orphan diseases. The company is primarily developing TOL2 drug candidate for treating myasthenia gravis, an autoimmune nerve and muscle disease. It also intends to develop TOL3 drug candidate to treat ANCA vasculitis, an autoimmune blood vessel disease. In addition, the company develops tolerogens technology, a treatment method that creates disease-specific tolerance in the immune system for treating various autoimmune diseases. The company was founded in 2011 and is headquartered in Gothenburg, Sweden.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2015-12-16
Stock Exchange
STO
Ticker
TOL.ST
According to Toleranzia AB’s latest financial reports and current stock price. The company's current Enterprise Value is 126.88M. This represents a change of 4.45% compared to the average of 121.47M of the last 4 quarters.
The mean historical Enterprise Value of Toleranzia AB over the last ten years is 52.09M. The current 126.88M Enterprise Value has changed 24.26% with respect to the historical average. Over the past ten years (40 quarters), TOL.ST's Enterprise Value was at its highest in in the December 2024 quarter at 137.16M. The Enterprise Value was at its lowest in in the September 2015 quarter at 0.
Average
52.09M
Median
42.13M
Minimum
7.59M
Maximum
111.80M
Discovering the peaks and valleys of Toleranzia AB Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.09%
Maximum Annual Enterprise Value = 111.80M
Minimum Annual Increase = -81.31%
Minimum Annual Enterprise Value = 7.59M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 111.80M | 182.84% |
| 2023 | 39.53M | -56.31% |
| 2022 | 90.47M | 1.09% |
| 2021 | 7.59M | -81.31% |
| 2020 | 40.58M | -12.17% |
| 2019 | 46.20M | 36.94% |
| 2018 | 33.74M | 8.90% |
| 2017 | 30.98M | -29.09% |
| 2016 | 43.69M | -42.80% |
| 2015 | 76.38M | -15.86% |
The current Enterprise Value of Toleranzia AB (TOL.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
80.60M
5-year avg
57.99M
10-year avg
52.09M
Toleranzia AB’s Enterprise Value is greater than AroCell AB (publ) (85.76M), less than Lipidor AB (publ) (164.67M), less than Dignitana AB (publ) (176.41M), greater than ISR Immune System Regulation Holding AB (publ) (42.87M), greater than Emplicure AB (publ) (33.32M), greater than RLS Global AB (publ) (15.17M), greater than IRRAS AB (publ) (118.83M), greater than CombiGene AB (publ) (-24839036.00), greater than FRISQ Holding AB (publ) (107.66M), greater than Kancera AB (publ) (8.45M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 85.76M | $132.23M | |
| 164.67M | $174.88M | |
| 176.41M | $172.36M | |
| 42.87M | $96.61M | |
| 33.32M | $46.47M | |
| 15.17M | $35.70M | |
| 118.83M | $181.75M | |
| -24839036.00 | $48.91M | |
| 107.66M | $46.74M | |
| 8.45M | $36.05M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Toleranzia AB using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Toleranzia AB or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Toleranzia AB's Enterprise Value?
What is the highest Enterprise Value for Toleranzia AB (TOL.ST)?
What is the 3-year average Enterprise Value for Toleranzia AB (TOL.ST)?
What is the 5-year average Enterprise Value for Toleranzia AB (TOL.ST)?
How does the current Enterprise Value for Toleranzia AB (TOL.ST) compare to its historical average?